Interleukin-27 inhibits vaccine-enhanced pulmonary disease following respiratory syncytial virus infection by regulating cellular memory responses

Journal of Virology

Volumn 86, Issue 8, 2012, Pages 4505-4517

  Zeng, Ruihong ^a   Zhang, Huixian ^a,b   Hai, Yan ^a   Cui, Yuxiu ^a   Wei, Lin ^a   Li, Na ^a,c   Liu, Jianxun ^a,c   Li, Caixia ^a   Liu, Ying ^a,d  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Hebei Province Blood Centre   (China)

^c Xingtai Medical College   (China)

^d Cangzhou Medical College   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMID VECTOR; RECOMBINANT VACCINE; TUMOR NECROSIS FACTOR ALPHA;

ADVERSE OUTCOME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG SAFETY; DRUG TOLERABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFECTION PREVENTION; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH17 CELL; TH2 CELL; VIRUS NEUTRALIZATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL LINE; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOLOGIC MEMORY; INFLAMMATION MEDIATORS; INTERLEUKIN-17; LUNG DISEASES; MICE; MICE, INBRED BALB C; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUSES; TH1 CELLS; TH17 CELLS; TH2 CELLS; VACCINES, DNA;

MUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 84861394111     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.07091-11     Document Type: Article

References (47)

1. Acosta-Rodriguez EV, et al. 2007. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8:639-646.
2. Artis D, et al. 2004. The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J. Immunol. 173:5626-5634.
3. Bermejo-Martin JF, et al. 2007. Persistence of proinflammatory response after severe respiratory syncytial virus disease in children. J. Allergy Clin. Immunol. 119:1547-1550.
4. Calarota SA, et al. 2008. IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine. Vaccine 26:5188-5195.
5. Castilow EM, Olson MR, Meyerholz DK, Varga SM. 2008. Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus. J. Virol. 82:2196-2207.
6. Chiyo M, et al. 2005. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. Int. J. Cancer 115:437-442.
7. Coffman RL, Seymour BW, Hudak S, Jackson J, Rennick D. 1989. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245:308-310.
8. Collins PL, Melero JA. 2011. Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res. 162: 80-99.
9. Diveu C, et al. 2009. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J. Immunol. 182:5748-5756.
10. Ebbert JO, Limper AH. 2005. Respiratory syncytial virus pneumonitis in immunocompromised adults: clinical features and outcome. Respiration 72:263-269.
11. Fan C, Mei X. 2005. Co-immunization of BALB/c mice with recombinant immunogens containingGprotein fragment and chimeric CTL epitope of respiratory syncytial virus induces enhanced cellular immunity and high level of antibody response. Vaccine 23:4453-4461.
12. Harrington LE, et al. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123-1132.
13. Hashimoto K, et al. 2005. Respiratory syncytial virus infection in the absence of STAT1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. J. Allergy Clin. Immunol. 116:550-557.
14. Hashimoto K, et al. 2004. Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and Gob-5. Am. J. Respir. Crit. Care Med. 170:306-312.
15. Henrickson KJ, Hoover S, Kehl KS, Hua W. 2004. National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr. Infect. Dis. J. 23:S11-S18.
16. Hsu SC, Chargelegue D, Steward MW. 1998. Reduction of respiratory syncytial virus titer in the lungs of mice after intranasal immunization with a chimeric peptide consisting of a single CTL epitope linked to a fusion peptide. Virology 240:376-381.
17. Hussell T, Baldwin CJ, O'Garra A, Openshaw PJ. 1997. CD8_ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur. J. Immunol. 27:3341-3349.
18. Johnson TR, Parker RA, Johnson JE, Graham BS. 2003. IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge. J. Immunol. 170:2037-2045.
19. Juntti H, et al. 2009. Cytokine responses in cord blood predict the severity of later respiratory syncytial virus infection. J. Allergy Clin. Immunol. 124:52-58.
20. Kastelein RA, Hunter CA, Cua DJ. 2007. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu. Rev. Immunol. 25:221-242.
21. Kim HW, et al. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:422-434.
22. Langrish CL, et al. 2004. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 202:96-105.
23. Lukacs NW, Smit JJ, Nunez G, Lindell DM. 2010. Respiratory virusinduced TLR7 activation controls IL-17 associated increase in mucus via IL-23 regulation. J. Immunol. 185:2231-2239.
24. Lukacs NW, et al. 2001. Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms. J. Immunol. 167:1060-1065.
25. Manjunath N, et al. 2001. Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J. Clin. Invest. 108:871-878.
26. Mok H, et al. 2007. Venezuelan equine encephalitis virus replicon parti-cles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats. J. Virol. 81:13710-13722.
27. Mukherjee S, et al. 2011. IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am. J. Pathol. 179:248-258.
28. Olson MR, Varga SM. 2007. CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease. J. Immunol. 179:5415-5424.
29. Openshaw PJ. 1995. Immunopathological mechanisms in respiratory syncytial virus disease. Springer Semin. Immunopathol. 17:187-201.
30. Oppmann B, et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715-725.
31. Power UF, et al. 2001. Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-or BBG2Na-immunized mice. J. Virol. 75:12421-12430.
32. Power UF, et al. 1997. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment. Virology 230: 155-166.
33. Prince GA, Curtis SJ, Yim KC, Porter DD. 2001. Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine J. Gen. Virol. 82:2881-2888.
34. Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-712.
35. Shimozato O, et al. 2006. The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects. Immunology 117:22-28.
36. Sigurs N, et al. 2005. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am. J. Respir. Crit. Care Med. 171:137-141.
37. Stensballe LG, et al. 2009. The causal direction in the association between respiratory syncytial virus hospitalization and asthma. J. Allergy Clin. Immunol. 123:131-137.
38. Stockinger B, Veldhoen M. 2007. Differentiation and function of Th17 T cells. Curr. Opin. Immunol. 19:281-286.
39. Szabo SJ, et al. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655-669.
40. Villarino A, et al. 2003. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19:645-655.
41. Waris ME, Tsou C, Erdman DD, Zaki SR, Anderson LJ. 1996. Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J. Virol. 70: 2852-2860.
42. Wua Q, et al. 2007. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect. 9:78-86.
43. Yoshida H, et al. 2001. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15:569-578.
44. Yoshimoto T, Yoshimoto T, Yasuda K, Mizuguchi J, Nakanishi K. 2007. IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation. J. Immunol. 179:4415-4423.
45. Yoshimura T, et al. 2006. Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J. Immunol. 177:5377-5385.
46. Zeng R, Gong W, Fan C, Mei X. 2006. Induction of balanced immunity in BALB/c mice by vaccination with a recombinant fusion protein containing a respiratory syncytial virusGprotein fragment and a CTL epitope. Vaccine 24:941-947.
47. Zeng R, Zhang Z, Mei X, Gong W, Wei L. 2008. Protective effect of a RSV subunit vaccine candidate G1F/M2 was enhanced by a HSP70-like protein in mice. Biochem. Biophys. Res. Commun. 377:495-499.